Severe Nervous System Complications After Botulinum Type A Therapy: Three Case Reports With Reviews of FDA-Reported Nervous System Adverse Effects

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PM & R 2012-08, Vol.4 (8), p.613-623
Hauptverfasser:	Hristova, Anna H., MD, Joseph, Lenore N., MD, Sathe, Swati A., MD, Wade, James B., PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Blepharospasm - drug therapy Botulinum Toxins, Type A - adverse effects Comorbidity Dystonia - drug therapy Female Humans Male Middle Aged Nervous System Diseases - chemically induced Physical Medicine and Rehabilitation United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!